Research Journal

Deep dives on peptide research, community signal, and the next wave of evidence questions.

EN/DE available on every page.

• Breaking the 30% Weight Loss Barrier: A Deep Dive into Eli Lilly's Retatrutide TRIUMPH-1 Phase 3 Trial Results

  An exhaustive scientific breakdown of the groundbreaking TRIUMPH-1 Phase 3 data for Retatrutide (LY3437943). Discover how this triple receptor agonist set a historic weight loss record, resolved the Glucagon Paradox, and drove significant cardiometabolic health markers.

  May 21, 202628 min

• The Transformation of Metabolic Medicine: Research Report on Peptide Innovation and Market Strategy 2026

  A deep dive into the evolution of metabolic therapy in 2026, shifting from simple GLP-1 approaches to complex polypharmacological precision strategies.

  March 4, 202618 min

• The Complete 2026 Peptide Research Landscape: Mechanisms, Evidence Matrices, and Where the Field Is Going

  An exhaustive long-form synthesis across all core peptides, combining mechanistic pathways, community signals, updated literature metrics, and future trial design.

  February 18, 202630 min

• Retatrutide and NAD+ Research in 2026: Metabolic Signal, Tri-Agonist Mechanisms, and What Comes Next

  A long-form research breakdown of RT10 and NAD+ projects: study design, tri-receptor dynamics, mass feedback, and future directions.

  February 22, 202624 min

• Ipamorelin, CJC No DAC, and the Synergy Stack: What Serious GH-Axis Research Looks Like in 2026

  A deep dive into IP5, CND5 and CP10 research: protocol structure, GHRH vs GHRP dynamics, community myths, and the future of pulse-based study design.

  February 21, 202623 min

• BPC-157, TB-500, and BB10 Stack Research: Angiogenesis, Actin Regulation, and the 2026 Evidence Gap

  Long-form coverage of BC5, TB5 and BB10 research focusing on VEGF expression, NO system interaction, mass feedback interpretation, and future study priorities.

  February 20, 202623 min

• Melanotan II and GHK-Cu Research in 2026: Melanocortin Pathways, Matrix Metalloproteinases, and Community Reality

  An advanced guide to ML10 and CU50 research, dissecting MC1R/MC4R agonism, collagen synthesis, community reports, and future evidence needs.

  February 19, 202620 min